|
|
|
|
|
|
|
VBI Vaccines Inc. (VBIV)
|
|
3.03 0 (0%)
|
06-22 16:00
|
|
Open:
|
3.02
|
Pre. Close:
|
3.03
|
|
High:
|
3.19
|
Low:
|
2.901
|
|
Volume:
|
906,426
|
Market Cap:
|
195M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
3.193 - 3.215
|
3.215 - 3.233
|
|
Low:
|
2.861 - 2.883
|
2.883 - 2.9
|
|
Close:
|
3 - 3.036
|
3.036 - 3.063
|
|
|
|
Technical analysis (as of: 2018-06-22 4:35:31 PM)
|
|
Overall:
|
|
|
Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.
|
|
Target:
|
Six months: 4.15 One year: 4.61
|
|
Support:
|
Support1: 2.90 Support2: 2.41
|
|
Resistance:
|
Resistance1:
3.55 Resistance2: 3.95
|
|
Pivot:
|
3.25 
|
|
Moving Averages:
|
MA(5): 3.13 MA(20): 3.20 
MA(100): 3.49 MA(250): 3.85
|
|
MACD:
|
MACD(12,26):
-0.01 Signal(12,26,9): 0.02
|
|
%K %D:
|
%K(14,3): 16.40 %D(3): 21.68
|
|
RSI:
|
RSI(14): 43.19
|
|
52-Week:
|
High: 5.1
Low: 2.82 Change(%): -29.4
|
|
Average Vol(K):
|
3-Month: 24166
10-Days 52042
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.VBIV has closed above bottom band by 30.8%. Bollinger Bands are 83.3% wider than normal. The large width of the bands suggest high volatility as compared to VBIV's normal range. The bands have been in this wide range for 7 bars. This is a sign that the current trend might continue.
|
|
|
Headline News
|
|
2018-05-27T00:21:17-04:00
Reader Inquiry: VBI Vaccines´ CEO Is Buying Shares, Should You?
2018-05-11T13:34:19-04:00
VBI Vaccines (VBIV) CMV Vaccine VBI - 1501A Final Phase I Data - Slideshow
2018-05-10T08:53:27-04:00
VBI's CMV vaccine candidate shows positive effect in early-stage study; shares ahead 11% premarket
2018-05-01T08:21:06-04:00
VBI Vaccines misses by $0.03
2018-04-13T01:03:46-04:00
Institutional Top Ideas Series: DAFNA Capital Management
2018-03-07T07:45:00-05:00
Pretenders And Ghosts: Stealth Promotion Network Exploits Financial Sites To Tout Stocks
2018-01-18T08:00:00-05:00
Your Daily Pharma Scoop: Juno Surges On Takeover Rumors, AEterna Zentaris Achieves Another Milestone, Spark Granted ODD
2018-01-17T09:29:32-05:00
Dosing underway in early-stage study of VBI Vaccines' VBI-1901 in GBM
|
|
|
Financial Analysis
|
|
Growth
|
NA
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
NA
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
NA
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
NA
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
